267 related articles for article (PubMed ID: 25075795)
1. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
2. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
Jiang JH; Pi J; Jin H; Cai JY
J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways.
Kang N; Zhang JH; Qiu F; Tashiro S; Onodera S; Ikejima T
Cancer Lett; 2010 Aug; 294(2):147-58. PubMed ID: 20202741
[TBL] [Abstract][Full Text] [Related]
4. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
Yang J; Ren X; Zhang L; Li Y; Cheng B; Xia J
Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993
[TBL] [Abstract][Full Text] [Related]
5. Oridonin Enhances Radiation-Induced Cell Death by Promoting DNA Damage in Non-Small Cell Lung Cancer Cells.
Park H; Jeong YJ; Han NK; Kim JS; Lee HJ
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104472
[TBL] [Abstract][Full Text] [Related]
6. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
[TBL] [Abstract][Full Text] [Related]
7. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.
Lu Y; Sun Y; Zhu J; Yu L; Jiang X; Zhang J; Dong X; Ma B; Zhang Q
Cell Death Dis; 2018 Jan; 9(1):15. PubMed ID: 29323103
[TBL] [Abstract][Full Text] [Related]
8. [Empirical study of oridonin-induced gastric cancer cells MKN45 apoptosis].
He XJ; Wang HJ; Xia YJ; Ye ZY; Tao HQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):607-10. PubMed ID: 19921575
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells.
Liu Y; Liu JH; Chai K; Tashiro S; Onodera S; Ikejima T
J Pharm Pharmacol; 2013 Nov; 65(11):1622-42. PubMed ID: 24102522
[TBL] [Abstract][Full Text] [Related]
10. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action.
Liu JJ; Huang RW; Lin DJ; Wu XY; Peng J; Pan XL; Lin Q; Hou M; Zhang MH; Chen F
Am J Hematol; 2006 Feb; 81(2):86-94. PubMed ID: 16432862
[TBL] [Abstract][Full Text] [Related]
12. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
14. Interruption of hepatocyte growth factor signaling augmented oridonin-induced death in human non-small cell lung cancer A549 cells via c-met-nuclear factor-κB-cyclooxygenase-2 and c-Met-Bcl-2-caspase-3 pathways.
Liu Y; Shi QF; Qi M; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2012; 35(7):1150-8. PubMed ID: 22791165
[TBL] [Abstract][Full Text] [Related]
15. Oridonin induces human epidermoid carcinoma A431 cell apoptosis through tyrosine kinase and mitochondrial pathway.
Li D; Wu LJ; Tashiro S; Onodera S; Ikejima T
J Asian Nat Prod Res; 2008; 10(1-2):77-87. PubMed ID: 18058384
[TBL] [Abstract][Full Text] [Related]
16. Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.
Bao R; Shu Y; Wu X; Weng H; Ding Q; Cao Y; Li M; Mu J; Wu W; Ding Q; Tan Z; Liu T; Jiang L; Hu Y; Gu J; Liu Y
BMC Cancer; 2014 Mar; 14():217. PubMed ID: 24655726
[TBL] [Abstract][Full Text] [Related]
17. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways.
Ikezoe T; Yang Y; Bandobashi K; Saito T; Takemoto S; Machida H; Togitani K; Koeffler HP; Taguchi H
Mol Cancer Ther; 2005 Apr; 4(4):578-86. PubMed ID: 15827331
[TBL] [Abstract][Full Text] [Related]
18. Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft.
Kong M; Fan J; Dong A; Cheng H; Xu R
Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):827-33. PubMed ID: 20978038
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds.
Huang Y; Chen Y; Mei Q; Chen Y; Yu S; Xia S
Oncol Rep; 2013 Jun; 29(6):2486-92. PubMed ID: 23525575
[TBL] [Abstract][Full Text] [Related]
20. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]